NT
Publicaties op Oncologisch.com
Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negati...
Adjuvant T-DM1 versus paclitaxel-trastuzumab bij stadium I HER2-positief: ATEMPT vijfjaars
Adjuvant T-DM1 versus paclitaxel-trastuzumab bij stadium I HER2-positief: ATEMPT fase II